Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Integrated Regional Information Networks - December 7, 2004
JOHANNESBURG, 7 December (PLUSNEWS) - A South African generic drug manufacturer has been granted a voluntary licence to produce and sell some GlaxoSmithKline antiretroviral (ARV) medication.
Under the terms of its agreement, Biotech, the fourth local company to receive a voluntary licence, will be able to supply ARVs to both the public and private markets throughout sub-Saharan Africa.
The South African Press Agency (SAPA) quoted GlaxoSmithKline's (GSK) Gunther Faber as saying: "The granting of this licence to Biotech Laboratories will, we feel, help to ease the situation in some measure, and reflects GSK's long-standing and continuing commitment to improve access to medicines in developing countries - a commitment we are proud of and will maintain far into the future."
Earlier this year GSK also granted a licence to a Kenyan company, Cosmos Limited, to supply, manufacture and sell ARV medication in Kenya and elsewhere in east Africa.
041207
IR041223
Copyright © 2004 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .